Fig. 6
From: Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
TERT-associated signatures harbor clinically actionable genes. a The mapping between FDA-approved drugs and their related clinically actionable genes (left) across cancer types (right). Yellow boxes indicate cancers with mutated genes, while black boxes indicate cancers without mutated genes. b The mapping between FDA-approved drugs and their related clinically actionable genes (left) and their average mRNA expression in cancer and adjacent normal samples across cancer types (right). High, TERT high group; Low, TERT low group; NC, adjacent normal sample group. Red indicates relatively high expression, while blue indicates relatively low expression